Funds and ETFs DBV Technologies

Equities

DBV

FR0010417345

Pharmaceuticals

Real-time Euronext Paris 09:06:20 2024-06-17 EDT 5-day change 1st Jan Change
0.961 EUR +1.05% Intraday chart for DBV Technologies -8.48% -48.03%
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.951 EUR
Average target price
4.4 EUR
Spread / Average Target
+362.67%
Consensus
  1. Stock Market
  2. Equities
  3. DBV Stock
  4. Funds and ETFs DBV Technologies